Pharmacists to present on pediatric behavioral health and cardiovascular drugs at American Drug Utilization Review Society conference

February 22, 2016

UMass Medical School pharmacists will discuss proposed regulations for managed care and display posters on a cardiovascular drug and a pediatric behavioral health medication safety initiative at the American Drug Utilization Review Society conference Feb. 25-27 at the DoubleTree Paradise Valley Resort in Scottsdale, Arizona.

Paul L. Jeffrey, PharmD, a pharmacy director in UMass Medical School’s Commonwealth Medicine division, will discuss the historical relationship between state Medicaid pharmacy programs and their managed Medicaid partners, significant challenges faced by Medicaid pharmacy programs, and the effect of the Centers for Medicare and Medicaid Services’ proposed Medicaid managed care regulation on the relationship of the affected entities. A pharmacy director in the Office of Clinical Affairs within the Center for Health Policy and Research, Jeffrey also serves as director of pharmacy for the Massachusetts Medicaid program, MassHealth. Jeffrey also is a clinical associate professor of UMass Medical School’s Family Medicine and Community Health. He will speak from 3:15 to 4:15 p.m. Feb. 26.

Two Commonwealth Medicine pharmacy posters will be on display at the conference Feb. 26 and 27. Vincent Palumbo, MBA, BS, RPh, program director of the Massachusetts Medicaid Drug Utilization Review Program in Clinical Pharmacy Services, will be on hand to answer questions.

Use of Clinical Evidence and Business Analytic Tools to Forecast Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitor Utilization in a State Medicaid Program

The poster will demonstrate how the evaluation of clinical evidence can be used to predict candidates for the treatment of cardiovascular disease with the PCSK9 inhibitor, describe the effect on a health plan through the use of claims data, and project the cost to the plan.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist in Clinical Pharmacy Services
Bonnie C. Greenwood, PharmD, BCPS, clinical program director in Clinical Pharmacy Services
Kimberly Lenz, PharmD,
assistant professor of Family Medicine and Community Health and a clinical pharmacy manager in the Office of Clinical Affairs
Amy L. Levy, MHP, BS, RPh, director of special projects in Clinical Pharmacy Services
Paul L. Jeffrey, PharmD, pharmacy director in the Office of Clinical Affairs

Preliminary Outcomes, Challenges, and Successes of a Pediatric Behavioral Health Medication Safety Initiative in a State Medicaid Program

The poster will describe the successful implementation of the Pediatric Behavioral Health Medication Safety Initiative, which focuses on the safe and effective use of behavioral medication in MassHealth members under age 18. The pharmacists concluded that outreach, interdisciplinary teamwork and care coordination are needed for successful interventions for pediatric MassHealth members who are prescribed behavioral health medication regimens.  

Donna M. Faber, PharmD, BCPS, clinical consultant pharmacist in Clinical Pharmacy Services
Kimberly Lenz, PharmD, an assistant professor of Family Medicine and Community Health and a clinical pharmacy manager in the Office of Clinical Affairs
Neha Kashalikar, PharmD, a clinical consultant pharmacist in Clinical Pharmacy Services
Patricia Leto, PharmD, clinical consultant pharmacist team lead in the Drug Utilization Review unit in Clinical Pharmacy Services 
Michael C. Angelini, MA
, PharmD, BCPP, behavioral health medicine consultant, and associate professor at MCPHS University
Vincent Palumbo, MBA, BS, RPh, program director of the Massachusetts Medicaid Drug Utilization Review Program in Clinical Pharmacy Services
Paul L. Jeffrey, PharmD, pharmacy director in the Office of Clinical Affairs